Read Time:5 Second
The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis said.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
